Studies have demonstrated that the reduction in SDH activity, resulting from the silencing of one of its subunits, promotes HCC cell proliferation and metastasis both in vitro and in vivo by increasing ROS and subsequently activating NF-κB signaling (Li et al., 2019). Here, SDHB is linked to hepatocellular carcinoma.